Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stefan Holdenrieder
Observed names:
Holdenrieder Stefan,
Holdenrieder, Stefan,
S. Holdenrieder
Institutions:
University of Bonn,
Deutsches Herzzentrum München,
Technical University of Munich
Observed institutions:
University of Bonn,
University Hospital Bonn,
Deutsches Herzzentrum München,
Institut für Laboratoriumsmedizin,
Technical University of Munich
ORCID:
0000-0001-8893-1253
Observed ORCID:
0000-0001-8893-1253
OpenAlex ID:
A5103194549
Clinically Meaningful Use of Blood Tumor Markers in Oncology
2016
·
Stefan Holdenrieder
, Lance Pagliaro
, et al.
·
BioMed Research International
·
76
PDF
Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes
2014
·
Sarah Kim
, Jessica Becker
, et al.
·
Nature Communications
·
74
PDF
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice
2016
·
Martin Wilhelm
, Lothar Mueller
, et al.
·
Clinical Colorectal Cancer
·
67
Acute metabolic effects of tonic‐clonic seizures
2019
·
Robert D. Nass
, Berndt Zur
, et al.
·
Epilepsia Open
·
52
PDF
Technical and clinical performance of a new assay to detect squamous cell carcinoma antigen levels for the differential diagnosis of cervical, lung, and head and neck cancer
2018
·
Stefan Holdenrieder
, Rafael Molina
, et al.
·
Tumor Biology
·
17
PDF
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) – study protocol for a pragmatic randomized controlled trial
2016
·
Julia Carolin Stingl
, Katharina Luise Kaumanns
, et al.
·
BMC Family Practice
·
14
PDF
Expression of soluble receptor for advanced glycation end products is associated with disease severity in congenital diaphragmatic hernia
2019
·
Florian Kipfmueller
, Katrin Heindel
, et al.
·
American Journal of Physiology-Lung Cellular and Molecular Physiology
·
9
PDF
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies
2015
·
Martin Coenen
, Annette Viktoria Hinze
, et al.
·
BMC Pharmacology and Toxicology
·
8
PDF
Interferon-beta-induced changes in neuroimaging phenotypes of appetitive motivation and reactivity to emotional salience
2019
·
Christoph Coch
, Roberto Viviani
, et al.
·
NeuroImage Clinical
·
7
PDF
In Response to “Serum Tumor Marker Use in Patients With Advanced Solid Tumors”
2016
·
Farshid Dayyani
, Dave Morgenstern
, et al.
·
Journal of Oncology Practice
·
4
Evaluation of cellulose pads as a method to detect cytomegalovirus DNA in neonatal urine
2018
·
Florian Kipfmueller
, Kira Jungbluth
, et al.
·
Annals of Clinical Biochemistry International Journal of Laboratory Medicine
·
1
Alterations Of The Chemokine Microenvironment In Chronic Lymphocytic Leukemia
2013
·
TILL M SEILER
, Roland Aydin
, et al.
·
Blood
·
1
Choriongonadotropin, humanes
2018
·
S. Holdenrieder
, P. Stieber
·
Springer eBooks
Kathepsine
2018
·
S. Holdenrieder
, P. Stieber
·
Springer eBooks
BRCA1
2017
·
S. Holdenrieder
, P. Stieber
·
Springer eBooks
Plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy.
2012
·
Oliver J. Stoetzer
, Holdenrieder Stefan
, et al.
·
Journal of Clinical Oncology
Role of Microenvironment-Associated Chemokines and Cytokines for Binet Stage A CLL Patients Included in a Prospective Trial (CLL1 trial) of the German CLL Study Group (GCLLSG): sIl2Ralpha Is An Independent Predictor of Progression-Free Survival (PFS),
2011
·
Till M Seiler
, Roland Aydin
, et al.
·
Blood
P.1.b.012 Relationship between kynurenines and S100b in CSF of schizophrenic patients
2006
·
M.J. Schwarz
, M. Riedel
, et al.
·
European Neuropsychopharmacology
Show more works
View as search
Works count:
20
Citation count:
330
H-index:
8
I10-index:
6
Year
Topic
Type